Literature DB >> 435335

Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture.

K S Albert, R D Welch, K A DeSante, A R DiSanto.   

Abstract

Oral coadministration of a single 250-mg tetracycline capsule and 60 ml of a bismuth subsalicylate antidiarrheal mixture reduced tetracycline absorption by 34% without appearing to perturb its absorption or disposition rate. A pronounced increase in intersubject tetracycline absorption variability also was noted. Apparently, the reduction in tetracycline bioavailability previously reported with a kaolin-pectin suspension is not peculiar to kaolin-pectin but can be expected with almost any antidiarrheal whose mechanism of action is adsorptive in nature.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 435335     DOI: 10.1002/jps.2600680518

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 2.  Adverse antibiotic drug interactions.

Authors:  A J Bint; I Burtt
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

3.  Effect of bismuth subsalicylate on ciprofloxacin bioavailability.

Authors:  L Rambout; J Sahai; K Gallicano; L Oliveras; G Garber
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.

Authors:  Yuanyuan Wang; Muh Akbar Bahar; Anouk M E Jansen; Janwillem W H Kocks; Jan-Willem C Alffenaar; Eelko Hak; Bob Wilffert; Sander D Borgsteede
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.